In this section
Data is submitted annually to the NHS Newborn Blood Spot Screening Programme regarding performance of the regional newborn blood spot programme in relation to key process and clinical referral standards.
Additionally data regarding blood spot quality and total ‘avoidable repeats’ is reported monthly to the NHS Newborn Blood Spot Screening Programme.
Performance data is also collated quarterly and reports are presented to the Greater Manchester and Lancashire and South Cumbria Quality and Commissioning Groups.
Newborn Screening Laboratory annual reports
Monthly avoidable repeat reports
- January 2020
- February 2020
- March 2020
- April 2020
- May 2020
- June 2020
- July 2020
- August 2020
- September 2020
- October 2020
- November 2020
- December 2020
- January 2021
- February 2021
- March 2021
- April 2021
- May 2021
- June 2021
Quarterly reports
- Quarter 4 2018/19
- Quarter 1 2019/20
- Quarter 2 2019/20
- Quarter 3 2019/20
- Quarter 4 2019/20
- Quarter 1 2020/21
- Quarter 2 2020/21
- Quarter 3 2020/21
- Quarter 4 2020/21
- Quarter 1 2021/22
Other reports/audits
- Postal audit by Helen Jopling, December 2012
- Blood spot sample quality project by Laura Hamilton, April 2013
- Sickle Screening Turnaround Time Re-audit by Suzanne Armitage, May 2014
- Carriers of abnormal haemoglobins – result communication audit by Helen Jopling, November 2014
- Audit of the linkage of antenatal and newborn screening results in the Sickle Cell and Thalassaemia Screening Programme in Greater Manchester, Lancashire and South Cumbria, May 2018
(Last reviewed September 2021)